Description
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 3/04: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Anorexiants; Antiobesity agents
A61P 3/04
Sub-Class
Stats
- 746 US PATENTS IN FORCE
- 218 US APPLICATIONS PENDING
- 200 Total Patent Owners
- 10,684 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 11998542 | Compositions and methods for reducing major adverse cardiovascular events | Nov 16, 20 | Jun 04, 24 | Nalpropion Pharmaceuticals LLC |
| 11980214 | Dietary fiber compositions with psyllium and methods of use | Nov 12, 20 | May 14, 24 | INOVOBIOLOGIC, INC. |
| 11980614 | Methods of treating RBP4 related diseases with triazolopyridines | Apr 12, 21 | May 14, 24 | Belite Bio, Inc; The Trustees of Columbia University in the City of New York; |
| 11981695 | Linoleic acid derivatives, pharmaceutical composition or food composition comprising said linoleic acid derivatives, and their uses | May 27, 19 | May 14, 24 | Université de Bourgogne; INSERM (Institut National de la Santé et de la Recherche Médicale); |
| 11976040 | Compounds for the reducing lipotoxic damage | Mar 03, 23 | May 07, 24 | Mayo Foundation for Medical Education and Research |
| 11970523 | Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof | May 06, 19 | Apr 30, 24 | China Pharmaceutical University |
| 11957704 | Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors | Aug 31, 22 | Apr 16, 24 | Regeneron Pharmaceuticals, Inc. |
| 11945794 | Nuclear transport modulators and uses thereof | Aug 23, 21 | Apr 02, 24 | KARYOPHARM THERAPEUTICS, INC. |
| 11938121 | Treatment of infections and biofilm formation using a cellulose synthase inhibitor | Apr 02, 21 | Mar 26, 24 | Purdue Research Foundation |
| 11938157 | TCI727/or its metabolites | Jul 13, 22 | Mar 26, 24 | TCI CO., LTD. |
| 11938172 | Method for regulating and controlling GLP-1/GLP-1R and drug | Jun 19, 18 | Mar 26, 24 | TALENGEN INTERNATIONAL LIMITED |
| 11939343 | Sting agonist compounds and methods of use | Sep 09, 21 | Mar 26, 24 | MERSANA THERAPEUTICS, INC. |
| 11931326 | Compositions and methods comprising sanshool as lip interacting components | Jul 08, 22 | Mar 19, 24 | DIET SHIELD LTD |
| 11932628 | Selective small molecule peptidomimetic melanocortin ligands | Jan 03, 22 | Mar 19, 24 | Minnesota Mining & Mfg. Co./Regents of the University of Minnesota |
| 11925660 | Treatment for obesity with superabsorbent materials | May 21, 21 | Mar 12, 24 | Not available |
| 11925671 | Process and compositions for enhancing energy expenditure | Jan 16, 21 | Mar 12, 24 | Not available |
| 11926618 | Halogen-substituted phenylate compound and applications thereof | Aug 20, 20 | Mar 12, 24 | HINOVA PHARMACEUTICALS INC. |
| 11918568 | Fused ring compound having urea structure | Jul 03, 19 | Mar 05, 24 | Sanford Burnham Prebys Medical Discovery Institute |
| 11920157 | Applications of butylidenephthalide | Sep 15, 22 | Mar 05, 24 | National Dong Hwa University |
| 11911445 | Peptide YY pharmaceutical formulations, compositions, and methods | Jan 23, 19 | Feb 27, 24 | Gila Therapeutics, Inc. |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0180,891 | SYNERGISTIC MODULATORS OF ALPHA-DICARBONYL DETOXIFICATION AND THEIR USE FOR INDUCING WEIGHT LOSS AND THE TREATMENT OF DIABETIC PATHOLOGIES | Dec 20, 21 | Jun 06, 24 | BUCK INSTITUTE FOR RESEARCH ON AGING |
| 2024/0180,898 | USE OF AMINOTHIAZOLE DERIVATIVE IN TREATMENT OF IMMUNE INFLAMMATION | Feb 02, 24 | Jun 06, 24 | Not available |
| 2024/0180,977 | COMPOSITIONS AND METHODS RELATING TO CLOSTRIDIUM COCHLEARIUM AND LACTOBACILLUS ACIDOPHILUS | Jun 06, 23 | Jun 06, 24 | Not available |
| 2024/0181,002 | COMPOSITION FOR ANTI-OBESITY COMPRISING GREEN TEA PEPTIDE COMPOSITION | Nov 21, 23 | Jun 06, 24 | Amorepacific Corporation |
| 2024/0181,015 | EFFECT OF GHRH ANTAGONISTS IN DIABETES AND OBESITY | Apr 04, 22 | Jun 06, 24 | Augusta University Research Institute, Inc.; Biomm Inc. & University of Miami; THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPT. OF VETERANS AFFAIRS; |
| 2024/0181,016 | POLYPEPTIDE CONJUGATES AND METHODS OF USES | Nov 03, 22 | Jun 06, 24 | Not available |
| 2024/0182,525 | NOVEL BICYCLIC COMPOUND, OPTICAL ISOMER THEREOF OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, USE THEREOF, AND PREPARATION METHOD THEREFOR | Mar 14, 22 | Jun 06, 24 | KOREARESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY |
| 2024/0173,344 | USE OF GABAA RECEPTOR AS TARGET IN PREPARATION OR SCREENING OF DRUG FOR LOWERING BLOOD LIPID LEVEL, TREATING OBESITY, AND/OR IMPROVING METABOLISM | Mar 28, 23 | May 30, 24 | SHANGHAI INSTITUTE OF ENDOCRINE AND METABOLIC DISEASES; RUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE; |
| 2024/0173,363 | MICROBIOME COMPOSITION OF HALOPHILIC BACILLUS VELEZENSIS KMU01 STRAIN FERMENTED CULTURE SUPERNATANT WITH ANTI-OBESITY EFFECT | Oct 18, 23 | May 30, 24 | Not available |
| 2024/0173,416 | PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF | Nov 03, 23 | May 30, 24 | Not available |
| 2024/0166,611 | TRIAZOLE DERIVATIVE AND USE THEREOF | Dec 22, 23 | May 23, 24 | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR |
| 2024/0166,708 | LONG ACTING PEPTIDE TYROSINE TYROSINE (PYY) ANALOGS AND METHODS OF USE | Jul 05, 23 | May 23, 24 | Not available |
| 2024/0156,771 | KETOGENIC COMPOSITIONS & METHODS OF USE THEREOF | Sep 26, 23 | May 16, 24 | Not available |
| 2024/0156,889 | A METHOD FOR REDUCING ANIMAL WEIGHT | Mar 11, 22 | May 16, 24 | Not available |
| 2024/0156,891 | EXTRACTS OF SALVIA MILTIORRHIZA AND/OR PONCIRUS TRIFOLIATA FOR INHIBITING BODY WEIGHT GAIN | Nov 02, 23 | May 16, 24 | TAIPEI MEDICAL UNIVERSITY; I-MEI FOODS CO., LTD.; |
| 2024/0158,497 | BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND LEPTIN RECEPTOR AND/OR GP130, AND METHODS OF USE THEREOF | Oct 25, 23 | May 16, 24 | Not available |
| 2024/0148,653 | SEMAGLUTIDE DEPOT SYSTEMS AND USE THEREOF | Dec 19, 23 | May 09, 24 | MAPI PHARMA LTD. |
| 2024/0148,743 | USES OF MELANOCORTIN-4 RECEPTOR AGONIST | Jan 20, 22 | May 09, 24 | LG Chem Ltd. |
| 2024/0148,815 | FOOD SUPPLEMENT TO PROMOTE BODY WEIGHT LOSS | Mar 08, 22 | May 09, 24 | Not available |
| 2024/0148,833 | COMPOSITION COMPRISING GLP-1 RECEPTOR AGONIST AND ACAT INHIBITOR | Nov 03, 23 | May 09, 24 | Not available |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 33 Months (last 2 years Issuances)
- 33 Months (last 5 years Issuances)